Friedrich Sinner
Magdeburg, ST, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 13, 2025
Prevalence and Impact on Quality of Life of Small Intestinal Bacterial Overgrowth (SIBO)-Related Symptoms in Patients with Upper Gastrointestinal Cancer.
Journal: Diseases (Basel, Switzerland)
Published: August 26, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.
Journal: Cancers
Published: February 03, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab.
Journal: Oncology letters
Published: September 06, 2024
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity.
Journal: JHEP reports : innovation in hepatology
Published: May 12, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy.
Journal: Hepatology (Baltimore, Md.)
Published: May 02, 2024
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.
Journal: JHEP reports : innovation in hepatology
Published: April 15, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events.
Journal: JHEP reports : innovation in hepatology
Published: October 04, 2023
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
Journal: Cancers
Published: October 10, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: June 28, 2022
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers.
Journal: Cancers
Published: February 07, 2022
Last Updated: 09/26/2026